Wei, R., Mao, L., Xu, P., Zheng, X., Hackman, R. M., Mackenzie, G. G., & Wang, Y. (2018). Suppressing glucose metabolism with Epigallocatechin-3-Gallate (EGCG) reduces breast cancer cell growth in preclinical models. Food Funct.

Wei, Ran, Limin Mao, Ping Xu, Xinghai Zheng, Robert M. Hackman, Gerardo G. Mackenzie, et Yuefei Wang. "Suppressing Glucose Metabolism With Epigallocatechin-3-Gallate (EGCG) Reduces Breast Cancer Cell Growth in Preclinical Models." Food Funct 2018.

Wei, Ran, et al. "Suppressing Glucose Metabolism With Epigallocatechin-3-Gallate (EGCG) Reduces Breast Cancer Cell Growth in Preclinical Models." Food Funct 2018.